Rice, Baylor College of Medicine make necessary step on road to 3-D bioprinting
In their work toward 3-D printing transplantable tissues and organs, bioengineers and scientists from Rice University and Baylor College of Medicine have demonstrated a key step on the path to generate implantable tissues with functioning capillaries.
In a paper published online in the journal Biomaterials Science, a team from the laboratories of Rice bioengineer Jordan Miller and Baylor College of Medicine biophysicist Mary Dickinson showed how to use a combination of human endothelial cells and mesenchymal stem cells to initiate a process called tubulogenesis that is crucial to the formation of blood-transporting capillaries.
The work is an important step with fragile endothelial cells (ECs) made from “induced pluripotent stem cells,” or iPSCs, a type of cell that can potentially be made from the cells of any human patient. Because iPSCs can be patient-specific, researchers hope to find ways of using them to generate tissues and replacement organs that can be transplanted without risk of rejection by a patient’s immune system. But the fragility of endothelial cells during laboratory growth has limited the utilization of this critical cell type, which is found in all vasculature.
“Our work has important therapeutic implications because we demonstrate utilization of human cells and the ability to live-monitor their tubulogenesis potential as they form primitive vessel networks,” said study lead author Gisele Calderon, a graduate student in Miller’s Physiologic Systems Engineering and Advanced Materials Laboratory.
“We’ve confirmed that these cells have the capacity to form capillary-like structures, both in a natural material called fibrin and in a semisynthetic material called gelatin methacrylate, or GelMA,” Calderon said. “The GelMA finding is particularly interesting because it is something we can readily 3-D print for future tissue-engineering applications.”
Tissue engineering, also known as regenerative medicine, is a field aimed at integrating advances in stem cell biology and materials science to grow transplantable replacement tissues and organs. While tissue engineers have found dozens of ways to coax stems cells into forming specific kinds of cells and tissues, they still cannot grow tissues with vasculature — capillaries and the larger blood vessels that can supply the tissues with life-giving blood. Without vascularization, tissues more than a few millimeters in thickness will die due to lack of nutrients, so finding a way to grow tissues with blood vessels is one of the most sought-after advances in the field.
Miller, who earned his Ph.D. at Rice in 2008, has studied vascularization in tissue engineering for more than 14 years. During his postdoctoral studies at the University of Pennsylvania, he also became heavily involved in the open-source 3-D printing movement, and his work at Rice combines both.
“Ultimately, we’d like to 3-D print with living cells, a process known as 3-D bioprinting, to create fully vascularized tissues for therapeutic applications,” said Miller, assistant professor of bioengineering. “To get there, we have to better understand the mechanical and physiological aspects of new blood-vessel formation and the ways that bioprinting impacts those processes. We are using 3-D bioprinting to build tissues with large vessels that we can connect to pumps, and are integrating that strategy with these iPS-ECs to help us form the smallest capillaries to better nourish the new tissue.”
Each of the trillions of living cells in the human body are constantly supplied with oxygen and nutrients by tiny blood vessels known as capillaries. Measuring just a few thousandths of a millimeter in diameter, some capillaries are so narrow that individual blood cells must squeeze through them in single-file. Capillaries are made entirely from networks of endothelial cells, the type of cell that lines the inner surface of every blood vessel in the human body.
In the process of tubulogenesis — the first step to making capillaries — endothelial cells undergo a series of changes. First, they form small, empty chambers called vacuoles, and then they connect with neighboring cells, linking the vacuoles together to form endothelial-lined tubes that can eventually become capillaries.
“We expect our findings will benefit biological studies of vasculogenesis and will have applications in tissue engineering to prevascularize tissue constructs that are fabricated with advanced photo-patterning and three-dimensional printing,” said Dickinson, the Kyle and Josephine Morrow Chair in Molecular Physiology and Biophysics at Baylor College of Medicine and adjunct professor of bioengineering at Rice.
In the study, Calderon, Rice undergraduate Patricia Thai and colleagues investigated whether commercially available endothelial cells grown from iPSCs had tubulogenic potential. The test examined this potential in two types of semisolid gels — fibrin and GelMA. Finally, the researchers also investigated whether a second type of stem cell, human mesenchymal stem cells, could improve the likelihood of tubulogenesis.
Calderon said fibrin was chosen for the experiment because it’s a natural material that’s known to induce tubulogenesis for wound healing. As such, the researchers expected endothelial cells would be induced to form tubules in fibrin.
Calderon said the first step in the experiments was to develop a third-generation lentivirus reporter to genetically modify the cells to produce two types of fluorescent protein, one located only in the nucleus and another throughout the cell. This permanent genetic modification allowed the team to noninvasively observe the cell morphology and also identify the action of each individual cell for later quantitative measurements. Next, the cells were mixed with fibrin and incubated for a week. Several times per day, Calderon and Thai used microscopes to photograph the growing samples. Thanks to the two fluorescent markers, time-lapse images revealed how the cells were progressing on their tubulogenic odyssey.
Calderon conducted advanced confocal microscopy at the Optical Imaging and Vital Microscopy Core facility at Baylor College of Medicine. Calderon and Thai then used an open-source software called FARSIGHT to quantitatively analyze the 3-D growth patterns and development character of the tubulogenenic networks in each sample. In fibrin, the team found robust tubule formation, as expected. They also found that endothelial cells had a more difficult time forming viable tubules in GelMA, a mix of denatured collagen that was chemically modified with methacrylates to allow rapid photopolymerization.
Over several months and dozens of experiments the team developed a workflow to produce robust tubulogenesis in GelMA, Calderon said. This involved adding mesenchymal stem cells, another type of adult human stem cell that had previously been shown to stabilize the formation of tubules.
Miller said that while clinical applications of 3-D bioprinting are expected to advance rapidly over the next few decades, even small tissue samples with working capillary networks could find use much more quickly for laboratory applications like drug testing.
“You could foresee using these three-dimensional, printed tissues to provide a more accurate representation of how our bodies will respond to a drug,” Miller said. “Preclinical human testing of new drugs today is done with flat two-dimensional human tissue cultures. But it is well-known that cells often behave differently in three-dimensional tissues than they do in two-dimensional cultures. There’s hope that testing drugs in more realistic three-dimensional cultures will lower overall drug development costs. And the potential to build tissue constructs made from a particular patient represents the ultimate test bed for personalized medicine. We could screen dozens of potential drug cocktails on this type of generated tissue sample to identify candidates that will work best for that patient.”
The Latest on: 3-D bioprinting
- Engineer Developing Methods, Applications to Construct Blood Vessels Using 3-D Printing Technology on September 15, 2017 at 6:57 am
Through inkjet bioprinting, Xu is able to more easily control the microspheres ... Then, numerous following layers are fabricated and stacked together to form a 3-D structure. Time depends on the size of the vascular structure, but Xu said an average ... […]
- Investment in 3D bioprinting and tech demo centers advances on September 15, 2017 at 4:53 am
In this round-up of recent additive manufacturing business and investment news we look at fund raising plans for several 3D bioprinting ventures, investment in high-tech centers across the world and increasing collaboration designed to bring additive ... […]
- Texas A&M engineering receives more grants from National Science Foundation on September 14, 2017 at 9:28 am
"This work will elucidate key fundamental properties of ionic covalent entanglement networks loaded with unique, 2-D nanoparticles, leading to transformative technology for 3-D bioprinting," Gaharwar said in a statement. "The work will lead to a novel ... […]
- 3D Bioprinting Market Research Reports & Industry Analysis & Trends on September 14, 2017 at 8:14 am
Market Research Future.com add new report of “3D Bioprinting Market Research Report – Global Forecast To 2027” it contains Company information, geographical data and Table of Content Study Objectives of 3D Bioprinting Market: - To provide detailed ... […]
- Market Research on 3D Bioprinting Market 2016 and Analysis to 2024 on September 13, 2017 at 10:03 pm
The global 3D bioprinting market is envisaged to offer some bankable prospects for industry players with technologies such as microextrusion 3D bioprinting making the cut on the basis of key factors such as affordability. The technology is expected to rake ... […]
- Bioprinting Organs: Researchers Create Less Expensive Bioink Based in 3D Printed Gelatin Hydrogels on September 13, 2017 at 1:00 am
They are using 3D printing and other techniques to create biomaterial products which are able to function right along living cells, and GeIMA serves as a major bioprinting building block. The UBC team created two different types of GeIMA hydrogels for ... […]
- Clay-based 'Laponite' bioink suitable for 3D bioprinting scaffolds with optimal drug delivery on September 12, 2017 at 1:53 pm
Within the field of bioprinting, the potential benefits of using clay-based printing materials are becoming increasingly apparent. As a recent research project by a team from the University of Southampton and the Technische Universitat Dresden in Germany ... […]
- Explore Global 3D bioprinting market forecast to 2022 on September 12, 2017 at 7:05 am
The Global 3D Bioprinting Market Report includes a comprehensive analysis of the present of the market. The report starts with the basic 3D Bioprinting Market overview and then goes into each and every detail. - Agency -. This is a professional and in ... […]
- Gaharwar awarded National Science Foundation grant to design next generation of inks for 3-D bioprinting on September 11, 2017 at 2:48 pm
Dr. Akhilesh K. Gaharwar, an assistant professor in the Department of Biomedical Engineering at Texas A&M University, has been awarded a National Science Foundation (NSF) grant for his work, “3-D Bioprinting of Complex Tissue Structures Using ... […]
- 3D Bioprinting Global Market Research Approach, Commercial Analysis and Forecast to 2022 on September 8, 2017 at 6:26 am
Syringe based 3D bioprinting technology held the major share in 3D bioprinting market as adoption rate of this technology is very high. Whereas, laser based technology is expected to grow at a higher CAGR during the forecast period. Medical segment has ... […]
via Google News and Bing News